SCHEMBL27632005

SCHEMBL27632005

Nc1ncc(F)c(-c2cccc(O)c2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.62
ADORA2A P29274 3/20 0.50
GFER P55789 1/20 0.50
KMT2A Q03164 1/20 0.50
ADORA2B P29275 1/20 0.50
CDC7 O00311 1/20 0.48
PIK3CG P48736 6/20 0.48
PIK3CA P42336 2/20 0.48
PIK3CB P42338 2/20 0.48
PIK3CD O00329 1/20 0.48
PIK3C2B O00750 1/20 0.48
PDXK O00764 1/20 0.48
GAK O14976 1/20 0.48
MAP3K7 O43318 1/20 0.48
RIPK2 O43353 1/20 0.48
PIP5K1C O60331 1/20 0.48
STK16 O75716 1/20 0.48
PIK3C2G O75747 1/20 0.48
PRKD3 O94806 1/20 0.48
OXSR1 O95747 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309649 0.80 ADORA1 (0.63) ADORA1ADORA2ACDC7
SCHEMBL30129635 0.78 HSD17B1 (0.47) ADORA1PIK3CGABL1FLT3HSD17B1
SCHEMBL30129595 0.78 RXFP1 (0.44) ADORA1PIK3CGHSD17B1HSD17B2
SCHEMBL1116418 0.76 PIK3CG (0.60) ADORA1ADORA2AADORA2BPIK3CGPIK3CA
SCHEMBL4355012 0.76 PIK3CG (0.63) ADORA1ADORA2AGFERKMT2AADORA2B
SCHEMBL27631647 0.75 PIK3CG (0.45) ADORA1ADORA2AGFERKMT2AADORA2B
SCHEMBL1116404 0.74 ADORA1 (0.70) ADORA1ADORA2AGFERKMT2APIK3CG
SCHEMBL1585912 0.73 PIK3CG (0.51) ADORA1ADORA2AADORA2BPIK3CGPIK3CA
SCHEMBL27631427 0.73 SYK (0.74) BRAF
SCHEMBL12575968 0.72 SRC (0.61) ADORA1PIK3CGPIK3CAPIK3CBPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 CN disclosed